2017 American Transplant Congress
Neutropenia in Kidney and Liver Transplant Recipients: Risk Factors and Consequences.
Aim: This study aimed to: 1) Define the risk factors associated with neutropenia within the first year post kidney or liver transplantation; 2) Describe the…2017 American Transplant Congress
Clostridium difficile Infection in Intestinal Transplant Recipients.
Background: Clostridium difficile infection (CDI) data in intestinal transplant (ITx) recipients is lacking. This study was performed to evaluate prevalence, risk factors, treatments and outcomes…2017 American Transplant Congress
Prophylactic Therapy Against Multidrug-Resistant Acinetobacter baumannii Contamination of Preservation Solution in Renal Transplantation: A Single Center Experience.
Kidney Disease Center, the First Affiliated Hospital, Zhejiang University, Hangzhou, China
Objectives: Rapidly increased multiple drug resistant (MDR) gram negative bacilli like Acinetobacter baumannii (AB) become the main pathogen in ICU nowdays. Our study is intended…2017 American Transplant Congress
Retrospective Analysis of Multiple Hemodialysis Access Modalities.
1Tampa General Hospital, Tampa, FL; 2University of South Florida, Tampa, FL
The use of native arteriovenous fistulas (AVF) for hemodialysis (HD) is the gold standard, however, for many patients, this is not an option. We hypothesize…2017 American Transplant Congress
Full Dose Cyclosporine Permanently Reverses Uncontrolled BK Viremia That Is Refractory to Tacrolimus Minimization.
Medicine, UCSD School of Medicine, San Diego, CA
Latent BK infection is benign and common in transplanted kidneys, but active infection causes viremia and kidney damage. Standard practice is to reduce tacrolimus (TAC)…2017 American Transplant Congress
Vancomycin Prophylaxis for Prevention of Clostridium difficile Recurrence in Renal Transplant Patients.
Purpose: Clostridium difficile infection (CDI) is higher in solid organ transplant recipients. IDSA/SHEA guidelines do not recommend prophylactic (PROPH) vancomycin (VANC) or metronidazole in CDI…2017 American Transplant Congress
Reducing the Early Readmission Rates in Kidney Transplantation.
Nephrology Division, Hospital do Rim Foudation, São Paulo, Brazil
Background: 30-day hospital readmission rate is a well-accepted quality metric and a predictor of mortality among kidney transplant recipients.Objective: The aim of this study is…2017 American Transplant Congress
De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.
Background: Donor (D)+/recipient (R)- serostatus is critically associated with an higher risk of cytomegalovirus (CMV) infection and disease. Antiviral prophylaxis is conventionally used in such…2017 American Transplant Congress
The Combined Effects of Induction Regimens and Antiviral Prophylaxis on the Risk of CMV Infection in Different Serostatus Subgroups After Liver Transplantation.
Introduction: Simultaneous effects of anti-CMV prophylaxis and induction regimens on cytomegalovirus (CMV) infection after liver transplantation (LTRs) have not been studied. We determined the magnitude…2017 American Transplant Congress
Clinical Utility of Viral miRNA in Urinary Exosomes to Diagnose BK Virus Nephropathy After Kidney Transplantation.
Polymerase chain reaction (PCR) demonstration of BK viral replication in plasma and urine supports the diagnosis of BK virus nephropathy (BKVN), an important cause of…
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 84
- Next Page »